News Releases

<< Back
Waters Corporation Presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Be Audio Webcast Live

MILFORD, Mass.--(BUSINESS WIRE)--Feb. 9, 2005--Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, today will speak to the investment community at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at the Grand Hyatt Hotel in New York at 2:00 p.m. eastern time.

Interested investors can access the live audio webcast of the presentation at www.waters.com under "What's New."

Waters Corporation holds worldwide leading positions in three complementary analytical technologies - high performance liquid chromatography (HPLC), mass spectrometry (MS), and thermal analysis (TA). These account for $4.5 - $5.0 billion of the overall $20+ billion analytical instrumentation market.

CONTACT:
Waters Corporation
Gene Cassis, 508-482-2349